Sinocelltech Group Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.27%

Sinocelltech Group Ltd (688520) has an Asset Resilience Ratio of 5.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688520 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥198.05 Million
≈ $28.98 Million USD Cash + Short-term Investments

Total Assets

CN¥3.76 Billion
≈ $550.42 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Sinocelltech Group Ltd's Asset Resilience Ratio has changed over time. See Sinocelltech Group Ltd (688520) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Sinocelltech Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sinocelltech Group Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥198.05 Million 5.27%
Total Liquid Assets CN¥198.05 Million 5.27%

Asset Resilience Insights

  • Limited Liquidity: Sinocelltech Group Ltd maintains only 5.27% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sinocelltech Group Ltd Industry Peers by Asset Resilience Ratio

Compare Sinocelltech Group Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Royalty Pharma Plc
NASDAQ:RPRX
Biotechnology 0.10%
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 3.28%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 4.52%
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
Biotechnology 35.56%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488
Biotechnology 4.35%

Annual Asset Resilience Ratio for Sinocelltech Group Ltd (None–None)

The table below shows the annual Asset Resilience Ratio data for Sinocelltech Group Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points

About Sinocelltech Group Ltd

SHG:688520 China Biotechnology
Market Cap
$2.68 Billion
CN¥18.34 Billion CNY
Market Cap Rank
#5282 Global
#1047 in China
Share Price
CN¥41.18
Change (1 day)
-0.39%
52-Week Range
CN¥35.89 - CN¥85.63
All Time High
CN¥101.80
About

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell… Read more